New Zealand markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
67.43+0.33 (+0.49%)
At close: 04:00PM EST
67.43 0.00 (0.00%)
After hours: 06:00PM EST

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500

IndustryMedical Devices
Full-time employees17,300

Key executives

NameTitlePayExercisedYear born
Mr. Bernard J. ZovighianCEO & Director1.04MN/A1968
Mr. Scott B. UllemCorporate VP & CFO1.09MN/A1967
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1.1M4.48M1966
Mr. Jean-Luc LemercierCorporate Vice President of Japan, Asia Pacific & Greater China1.24M3.05M1957
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVice President of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorporate VP & General CounselN/AN/A1959
Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsN/AN/AN/A
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1.26M11.63M1962
Ms. Christine Z. McCauleyCorporate Vice President of Human ResourcesN/AN/A1965
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate governance

Edwards Lifesciences Corporation’s ISS governance QualityScore as of 28 November 2023 is 3. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 4; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.